Results 121 to 130 of about 154,396 (266)

Metabolic and Microvascular Risk Factors Associated With Brain Health in Type 1 Diabetes

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT We examined relationships between metabolic factors, microvascular complications, and brain health in adults with type 1 diabetes. Fifty‐one adults were assessed for metabolic risk factors, microvascular complications, and cognitive function, with a subset completing brain MRI.
Jihyun Park, Emily J. Koubek, Richard Beare, Lynn Ang, Brian C. Callaghan, Rodica Pop‐Busui, Eva L. Feldman, Evan L. Reynolds   +7 more
wiley   +1 more source

Spontaneous Splenic Rupture in a Patient With Combined Congenital Factor XIII and Factor VII Deficiencies: A Case Report. [PDF]

Cureus
Khan MAM, Pathan YA, Asjad M, Benoj AA, Pradeep G, Abdulla G, Younus HA, Nasar I.   +7 more
europepmc   +1 more source

Sex‐Stratified Association of Regional Dopamine Transporter Binding With Disease Progression in Amyotrophic Lateral Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To clarify the clinical relevance of dopamine transporter single‐photon emission computed tomography (DAT‐SPECT) abnormalities in amyotrophic lateral sclerosis (ALS), with a prespecified focus on sex‐stratified associations with disease progression and short‐term prognosis.
Tomoya Kawazoe, Keizo Sugaya, Kentaro Hayashi, Keiko Hino, Yasuhiro Nakata, Kota Bokuda, Toshio Shimizu, Kazushi Takahashi   +7 more
wiley   +1 more source

A Phenotype-driven strategy for bilateral VATS in severe factor VII deficiency: securing hemostasis without complete parameter correction. [PDF]

J Cardiothorac Surg
Yao YP, Bian HC, Liu Y, Chen Z, Xin N, Xu RX.   +5 more
europepmc   +1 more source

Mutations of TFPI-binding exosites on factor VII cause bleeding phenotypes in factor VII deficiency. [PDF]

Blood Adv, 2022
Seanoon K, Payongsri P, Vivithanaporn P, Sirachainan N, Chuansumrit A, Hongeng S, Tanratana P.   +6 more
europepmc   +1 more source

Thrombosis and Factor VII Activity [PDF]

Journal of Clinical Pathology, 1957
openaire   +2 more sources

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito, Kamal Benguerba, Ken Tsuchida, Kazushige Yazawa, Isao Tsumiyama, Hiromitsu Kayama, Sandra P. Reyna, Farid Khan, Richard S. Finkel   +8 more
wiley   +1 more source

Congenital factor VII deficiency: When to suspect?

Pediatric Hematology Oncology Journal, 2016
Ankit Ranjan, Sushma Malik, Poonam Wade, Purvi Kadakia   +3 more
doaj   +1 more source

Safety of recombinant activated factor VII for bleeding use post Heart Mate III, left ventricular assist device implantation. [PDF]

JHLT Open
Al-Kaf FA, AlRifaie R, Songor H, Alreshidan M.   +3 more
europepmc   +1 more source

Acquired isolated factor VII deficiency in a patient with myxoid pleomorphic liposarcoma, case report. [PDF]

Medicine (Baltimore), 2023
Aljabry M, Aleid M, Almutairi S, AlSerhani R, Alsahil S, Alotaibi G.   +5 more
europepmc   +1 more source